Expiration date: 12/2024

Pharmaceutical group 



One tablet contains 250 mg of metamizol sodium, 20 mg bendazol, 20 mg of papaverine hydrochloride, 20 mg of phenobarbital.

Indications for use

Pain, mostly associated with spasms of smooth muscles of the gastrointestinal tract, and peripheral vessels or of vessels of a brain.

Pharmacological action:

Antispasmodic (relieves spasms), vasodilator and analgesic remedy. Properties of the drug are associated with its constituent components.

Metamizole sodium has analgesic and antipyretic effect.

Bendazol and papaverine hydrochloride reduce the tone of smooth muscles of internal organs, causing the peripheral vessels. Phenobarbital has a sedative effect.

Method of application

1-2 tablets 2-3 times a day.

Interaction with other drugs

No data.


  • Expressed human liver and/or kidneys 
  • the deficit glukozo-6-fosfatdegidrogenaza, 
  • diseases of the blood, 
  • hypersensitivity to the drug.

Side effects

Allergic reactions are possible.

With prolonged use, eat cases, leucopenia, agranulocytosis.


No data.

Dosage form

10 or 20 tablets

The conditions of the premise

List B. In the dark place.